Multiple Sclerosis Trial, Recruiting ISRCTN10088443 Sponsor: Cambridge University Hospitals NHS Foundation Trust Condition: Multiple Sclerosis
Back to Multiple Sclerosis

Multiple Sclerosis Trial, Recruiting

ISRCTN10088443
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For people with Multiple Sclerosis (MS):

  • Adults aged 18 or older with a confirmed diagnosis of MS
  • People who are aware of and understand their MS diagnosis
  • People who are able to sign a written consent form agreeing to take part
  • People who are willing and able to attend scheduled visits and complete all required study procedures, including scans and lab tests

For healthy volunteers (people without MS):

  • Adults aged 18 or older
  • People who are able to sign a written consent form agreeing to take part
  • People who are willing and able to attend scheduled visits and complete all required study procedures, including scans and lab tests

Who may not be able to join:

For both people with MS and healthy volunteers:

  • People with uncontrolled diabetes or conditions that affect blood sugar levels, or who take medications that affect blood sugar
  • People with any other medical condition that the research team considers may make participation unsafe or unsuitable
  • People with a known allergy or adverse reaction to the contrast agents used in this study, including gadolinium-based agents or pyruvate
  • People who are unable to have an MRI scan for any reason, such as having a permanent pacemaker, severe obesity, or being unable to lie still
  • People who are pregnant or breastfeeding

Additionally, for healthy volunteers only:

  • People with any past or current neurological condition that the research team considers significant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from the ISRCTN registry. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 10 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Cambridge University Hospitals NHS Foundation Trust
Registry
ISRCTN registry
Start date
30 March 2016
Est. completion
31 December 2026

Where this trial is recruiting

England 🇬🇧 United Kingdom

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from the ISRCTN registry: 10 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ISRCTN ↗

Source: ISRCTN registry (isrctn.com), data processed 10 July 2026. ISRCTN metadata is CC0; contribution content is CC BY 4.0.